V. Floch

发表

Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes.

C. Férec, S. Loisel, C. Le Gall, 2001, Human gene therapy.

FACTORS INFLUENCING THE EFFICIENCY OF LIPOPLEXES MEDIATED GENE TRANSFER IN LUNG AFTER INTRAVENOUS ADMINISTRATION*

C. Férec, S. Loisel, C. Le Gall, 2001, Journal of liposome research.

Transgene expression kinetics after transfection with cationic phosphonolipids in hematopoietic non adherent cells.

C. Férec, C. Guillaume, J. Yaouanc, 1998, Biochimica et biophysica acta.

Cationic phosphonolipids as non viral vectors for DNA transfection in hematopoietic cell lines and CD34+ cells.

C. Férec, J. Yaouanc, J. Clement, 1997, Blood cells, molecules & diseases.

Novel Cationic Phosphonolipids Agents for in Vitro Gene Transfer to Epithelial Cell Lines

C. Férec, J. Yaouanc, J. Clement, 1997 .

New biocompatible cationic amphiphiles derivative from glycine betaine: a novel family of efficient nonviral gene transfer agents.

C. Férec, C. Guillaume, T. Benvegnu, 1998, Biochemical and biophysical research communications.

Systemic administration of cationic phosphonolipids/DNA complexes and the relationship between formulation and lung transfection efficiency.

C. Férec, C. Guillaume, P. Delépine, 2000, Biochimica et biophysica acta.

Cationic phosphonolipids as nonviral vectors: in vitro and in vivo applications.

C. Férec, C. Guillaume, P. Delépine, 2000, Journal of pharmaceutical sciences.

Phosphonolipids as non-viral vectors for gene therapy

C. Férec, J. Yaouanc, J. Clement, 1998 .

Cation substitution in cationic phosphonolipids: a new concept to improve transfection activity and decrease cellular toxicity.

C. Férec, J. Yaouanc, J. Clement, 2000, Journal of medicinal chemistry.

Cationic phosphonolipids as nonviral gene transfer agents in the lungs of mice.

C. Férec, J. Yaouanc, J. Clement, 1998, Human gene therapy.

Caecum: A Potential Site for Studying Gene Transfer in vivo

C. Férec, C. Guillaume, P. Delépine, 2000 .